Reset Therapeutics is a biopharmaceutical company formed to discover, develop and commercialize new therapeutics that modulate the circadian system, the body’s network of internal molecular clocks. The circadian system synchronizes behavioral and physiological processes, including sleep, metabolism, feeding, blood pressure and hormone secretion with the environmental cycles of light, activity and nutrient status. Disruption of normal circadian rhythms is associated with many diseases, including central nervous system, cardiovascular and metabolic disorders, immune system dysfunction and cancer. Novel therapies that reset the body’s biological clocks have the potential to benefit very large and diverse patient populations.
Looking for a particular Reset Therapeutics employee's phone or email?
The Reset Therapeutics annual revenue was $8.4 million in 2026.
Reset Therapeutics is based in South San Francisco, California.
The NAICS codes for Reset Therapeutics are [325, 32, 3254].
The SIC codes for Reset Therapeutics are [283, 28].